Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bioavailability Enhancement: Drug Permeability Enhancement

Bioavailability Enhancement: Drug Permeability Enhancement

Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...

Olefin Metathesis Polymerization: Acyclic Diene Metathesis (ADMET)

Olefin Metathesis Polymerization: Acyclic Diene Metathesis (ADMET)

Acyclic diene metathesis polymerization or ADMET polymerization involves cross-metathesis of terminal dienes, such as 1,8-nonadiene, to give linear unsaturated polymer and ethylene. As ADMET is a reversible process, the formed ethylene gas must be removed from the reaction mixture to complete the polymerization process.
Similar to cross-metathesis, ADMET also involves the formation of metallacyclobutane intermediate by [2+2] cycloaddition of one of the double bonds of a terminal diene with...

Drug Delivery: Enteral Route

Drug Delivery: Enteral Route

The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Collision metastasis of lung adenocarcinoma and melanoma presenting as a fungating axillary mass.

JAAD case reports·2026

Same author

Multibacillary leprosy relapse presenting as hypopigmented patches and concurrent erythema nodosum leprosum after initial multidrug therapy.

Dermatology online journal·2026

Same author

Exfoliative Erythroderma Revealing Primary Central Nervous System Diffuse Large B-Cell Lymphoma.

Cureus·2026

Same author

A Review of The Efficacy of Complementary and Alternative Medicines in Managing Dermatologic Infectious Diseases.

The Journal of clinical and aesthetic dermatology·2026

Same author

Postoperative Staphylococcal Toxic Shock Syndrome in a Patient Following Right Knee Fracture Repair: A Case Report.

Cureus·2025

Same author

Updated cross-sectional prevalence data for lichen sclerosus in the All-of-Us database: implications for current routine genital skin examination practices.

International journal of women's dermatology·2025

Search research articles

Related Experiment Video

Updated: Dec 27, 2025

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Published on: November 29, 2024

Ingenol Mebutate: Expanded Utility

Yasmin Khalfe, Theodore Rosen

Journal of Drugs in Dermatology : JDD

|March 5, 2020

Summary

Ingenol mebutate (IM) effectively treats actinic keratosis (AK) through cell death and immune responses. This review explores its successful off-label use for various other skin conditions beyond AK.

Area of Science:

Dermatology
Pharmacology

Background:

Ingenol mebutate (IM) is a topical drug approved for actinic keratosis (AK).
It exhibits a dual mechanism of action: rapid necrosis and delayed neutrophil-mediated cytotoxicity.
Current FDA approval is limited to AK treatment.

Purpose of the Study:

To review existing literature on the efficacy of ingenol mebutate for dermatologic disorders.
To explore off-label applications of ingenol mebutate beyond its approved indication for AK.

Main Methods:

Literature review of studies investigating ingenol mebutate.
Analysis of evidence for treatment of various skin conditions.

Main Results:

Ingenol mebutate has demonstrated efficacy in treating conditions beyond actinic keratosis.

More Related Videos

Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye

Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye

Published on: March 30, 2020

Minimally Invasive Muscle Embedding MIME - A Novel Experimental Technique to Facilitate Donor-Cell-Mediated Myogenesis

Minimally Invasive Muscle Embedding MIME - A Novel Experimental Technique to Facilitate Donor-Cell-Mediated Myogenesis

Published on: August 24, 2017

Related Experiment Videos

Last Updated: Dec 27, 2025

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Published on: November 29, 2024

Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye

Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye

Published on: March 30, 2020

Minimally Invasive Muscle Embedding MIME - A Novel Experimental Technique to Facilitate Donor-Cell-Mediated Myogenesis

Minimally Invasive Muscle Embedding MIME - A Novel Experimental Technique to Facilitate Donor-Cell-Mediated Myogenesis

Published on: August 24, 2017

Off-label use shows potential for multiple dermatologic disorders.

Conclusions:

Ingenol mebutate possesses therapeutic potential for a range of skin conditions.
Further research into its off-label applications is warranted.